Rain Oncology Inc. Quarterly Debt-to-equity in % from Q3 2021 to Q3 2023

Taxonomy & unit: ratio: %
Description: Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary: Rain Oncology Inc. quarterly Debt-to-equity history and growth rate from Q3 2021 to Q3 2023.
Rain Oncology Inc. Debt-to-equity for the quarter ending September 30, 2023 was 21.5 %, a 64% increase year-over-year.

Debt-to-equity, Quarterly (%)

Debt-to-equity, YoY Quarterly Growth (%)

Period	Value	YoY Chg	Change %	Date
Q3 2023	21.5	+8.37	+64%	Sep 30, 2023
Q2 2023	20.3	+9.34	+85.5%	Jun 30, 2023
Q1 2023	17.4	+8.25	+90.2%	Mar 31, 2023
Q4 2022	15	+4.09	+37.5%	Dec 31, 2022
Q3 2022	13.1	-0.19	-1.43%	Sep 30, 2022
Q2 2022	10.9			Jun 30, 2022
Q1 2022	9.14			Mar 31, 2022
Q4 2021	10.9			Dec 31, 2021
Q3 2021	13.3			Sep 30, 2021

* An asterisk sign (*) next to the value indicates that the value is likely invalid.